| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.32 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.01 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |